Gulf Medical Projects Co.

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: AEG000401014
AED
2.00
0.04 (2.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 5.70% over the last 5 years

 
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

AED 1,433 Million (Micro Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

7.32%

stock-summary
Debt Equity

-0.20

stock-summary
Return on Equity

9.04%

stock-summary
Price to Book

1.26

Revenue and Profits:
Net Sales:
180 Million
(Quarterly Results - Mar 2025)
Net Profit:
29 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.41%
0%
-7.41%
6 Months
-2.91%
0%
-2.91%
1 Year
2.56%
0%
2.56%
2 Years
5.26%
0%
5.26%
3 Years
21.95%
0%
21.95%
4 Years
17.65%
0%
17.65%
5 Years
-12.28%
0%
-12.28%

Gulf Medical Projects Co. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.72%
EBIT Growth (5y)
16.80%
EBIT to Interest (avg)
19.14
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.56
Tax Ratio
8.17%
Dividend Payout Ratio
134.65%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.59%
ROE (avg)
6.44%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.37
EV to EBIT
19.39
EV to EBITDA
13.53
EV to Capital Employed
1.44
EV to Sales
1.90
PEG Ratio
0.71
Dividend Yield
7.04%
ROCE (Latest)
7.43%
ROE (Latest)
8.52%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 7.78% vs 22.87% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 24.57% vs 38.92% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "180.10",
          "val2": "167.10",
          "chgp": "7.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.30",
          "val2": "28.50",
          "chgp": "-14.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.50",
          "val2": "-0.50",
          "chgp": "800.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.90",
          "val2": "23.20",
          "chgp": "24.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "93.10%",
          "val2": "128.90%",
          "chgp": "-3.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.91% vs 13.06% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 32.98% vs 72.87% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "677.30",
          "val2": "569.60",
          "chgp": "18.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "100.20",
          "val2": "73.70",
          "chgp": "35.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "2.00",
          "chgp": "10.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "10.30",
          "val2": "8.60",
          "chgp": "19.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "100.00",
          "val2": "75.20",
          "chgp": "32.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "105.60%",
          "val2": "81.30%",
          "chgp": "2.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoYstock-summary
Mar'25
Mar'24
Change(%)
Net Sales
180.10
167.10
7.78%
Operating Profit (PBDIT) excl Other Income
24.30
28.50
-14.74%
Interest
0.60
0.60
Exceptional Items
3.50
-0.50
800.00%
Consolidate Net Profit
28.90
23.20
24.57%
Operating Profit Margin (Excl OI)
93.10%
128.90%
-3.58%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2025 is 7.78% vs 22.87% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is 24.57% vs 38.92% in Mar 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
677.30
569.60
18.91%
Operating Profit (PBDIT) excl Other Income
100.20
73.70
35.96%
Interest
2.20
2.00
10.00%
Exceptional Items
10.30
8.60
19.77%
Consolidate Net Profit
100.00
75.20
32.98%
Operating Profit Margin (Excl OI)
105.60%
81.30%
2.43%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 18.91% vs 13.06% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 32.98% vs 72.87% in Dec 2023

stock-summaryCompany CV
About Gulf Medical Projects Co. stock-summary
stock-summary
Gulf Medical Projects Co.
Hospital
Gulf Medical Projects Co PSC is a United Arab Emirates-based public shareholding company, which operates in the healthcare sector. The main activity of the Gulf Medical Projects Co PSC and its subsidiaries, together referred to as the Group, include general hospital, general clinic, import, hospital management, construction of medicine product factories, trading in medical equipment and its instruments, medicine and medical tools. The Company’s subsidiaries are: Al Zahra Pvt Hospital Dubai LLC, which operates as a general hospital and Al Zahra Neurosciences International LLC, which is engaged in investment in healthcare enterprises and development. The Company operates under the following segments: Health Services and Others, which is mainly providing health, medical care and other related services, as well as Investments, which is mainly concerned with investment properties and investment in securities.
Company Coordinates stock-summary
Company Details
S.B: 3499 , SHARJAH None : None
stock-summary
Tel: 971 6 5095555971 6 5168829
stock-summary
Registrar Details